(Q40604583)

22 September 2017

title

Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia (English)

1 reference

22 September 2017

Paganini H

1

1 reference

22 September 2017

Rodriguez-Brieshcke T

2

1 reference

22 September 2017

Zubizarreta P

3

1 reference

22 September 2017

Latella A

4

1 reference

22 September 2017

Firpo V

5

1 reference

22 September 2017

Casimir L

6

1 reference

22 September 2017

Armada A

7

1 reference

22 September 2017

Fernández C

8

1 reference

22 September 2017

Cáceres E

9

1 reference

22 September 2017

Debbag R

10

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

22 September 2017

1 reference

22 September 2017

volume

91

1 reference

22 September 2017

issue

8

1 reference

22 September 2017

page(s)

1563-1567

1 reference

The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Approaching the controversies in antibacterial management of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Early discharge of low-risk febrile neutropenic children and adolescents with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Oral administration of cefixime to lower risk febrile neutropenic children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Predicting the risk of bacteremia in childen with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Ciprofloxacin safety in a pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

Use of fluoroquinolones as prophylactic agents in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1563%3A%3AAID-CNCR1166%3E3.0.CO%3B2-C

10.1002/1097-0142(20010415)91:8<1563::AID-CNCR1166>3.0.CO;2-C

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference